Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mika Geva"'
Autor:
Mika Geva, Shalev Fried, Orit Itzhaki, Noga Shem-Tov, Ivetta Danylesko, Ronit Yerushalmi, Ronit Marcus, Inbal Sdayoor, Ronnie Shapira-Frommer, Meirav Kedmi, Roni Shouval, Arnon Nagler, Avichai Shimoni, Abraham Avigdor
Publikováno v:
HemaSphere, Vol 7, p e62933fb (2023)
Externí odkaz:
https://doaj.org/article/e0575545a9cb4703885b16f12c06ef66
Autor:
Mika Geva, Gadi Shlomai, Anat Berkovich, Elad Maor, Avshalom Leibowitz, Alexander Tenenbaum, Ehud Grossman
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Background Prediabetes is a well-established risk factor for progression to overt diabetes mellitus (DM), which is in turn associated with development of hypertension (HTN) and vice versa. However, the role of prediabetes and HbA1c in partic
Externí odkaz:
https://doaj.org/article/7abd5c7b35b84330acf1d4225c43679c
Publikováno v:
Clinical Hematology International, Vol 1, Iss 1 (2019)
The growing understanding of the bidirectional relationship between the gastrointestinal (GI) microbiome and the immune system has opened up new avenues for treatment of graft-versus-host disease (GVHD). Fecal microbiota transplantation (FMT) is the
Externí odkaz:
https://doaj.org/article/30d229bd21df4432ae393791bee34854
Autor:
Joshua A Fein, David Bomze, Arnon Nagler, Adi Eshel, Roni Shouval, Mika Geva, Omry Koren, Ivetta Danylesko, Avichai Shimoni, Tsila Zuckerman, Israel Henig, Ilan Youngster, Itai Sharon
Publikováno v:
Blood Advances. 6:568-573
We observed high rates of bloodstream infections (BSIs) following fecal microbiota transplantation (FMT) for graft-versus-host-disease (33 events in 22 patients). To trace the BSIs' origin, we applied a metagenomic bioinformatic pipeline screening do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca69dc97f515669b51f1c2d09b08e629
https://doi.org/10.1182/bloodadvances.2021005110
https://doi.org/10.1182/bloodadvances.2021005110
Autor:
Roni Shouval, Angharad Pryce, Richard Szydlo, Avichai Shimoni, Jiri Pavlu, Mika Geva, Arnon Nagler, Noga Shem-Tov, Ivetta Danylesko, Joshua A Fein, Ronit Yerushalmi
Publikováno v:
Bone Marrow Transplantation. 56:2690-2696
Risk stratification is important for balancing potential risks and benefits of allogeneic hematopoietic stem cell transplantation (HSCT) for hematological malignancies. We retrospectively studied 1119 patients undergoing allogenic-HSCT in a single ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a58c3f0d32fc4bc86c23c2de7637c0
https://doi.org/10.1038/s41409-021-01377-9
https://doi.org/10.1038/s41409-021-01377-9
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e947-e955
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5847633c683c9d322b7f1c976d1ee049
https://doi.org/10.1016/j.clml.2020.07.016
https://doi.org/10.1016/j.clml.2020.07.016
Autor:
Elizaveta Kouniavski, Amir A. Kuperman, Ayelet Armon-Omer, Cecilia Noecker, Joshua A Fein, Arnon Nagler, Mika Geva, Bar Dubovski, Elhanan Borenstein, Roni Shouval, Hadar Neuman, Omry Koren, Shalev Fried, Adi Eshel, Yoram Louzoun, Radi Shahien, Efrat Muller, Ivetta Danylesko
Publikováno v:
Blood Adv
Oral mucositis (OM) is a common debilitating dose-limiting toxicity of cancer treatment, including hematopoietic stem cell transplantation (HSCT). We hypothesized that the oral microbiome is disturbed during allogeneic HSCT, partially accounting for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8a057db4d63d4c6c51cfce741fe627
https://doi.org/10.1182/bloodadvances.2020001827
https://doi.org/10.1182/bloodadvances.2020001827
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75e53e398b02b5404b548a409d617ade
https://doi.org/10.1016/s2152-2650(22)00605-x
https://doi.org/10.1016/s2152-2650(22)00605-x
Autor:
Moshe E. Gatt, Efrat Luttwak, Svetlana Trestman, Irit Avivi, Tamar Tadmor, Kreiniz Natalia, Noam Benyamini, Eyal Lebel, Noa Lavi, Celia Suriu, Moshe Mittelman, Netanel A. Horowitz, Ory Rouvio, Yael C Cohen, Mika Geva
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(11)
Background Lenalidomide and ixazomib maintenance improve long-term outcomes in newly diagnosed multiple myeloma (NDMM) patients. However, there is less evidence to support bortezomib (BTZ) maintenance therapy, and real-life data on maintenance are sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16fd8119e038da5f8208f3f5dce4a200
https://pubmed.ncbi.nlm.nih.gov/32624446
https://pubmed.ncbi.nlm.nih.gov/32624446
Autor:
Ronit Yerushalmi, Avichai Shimoni, Joshua A Fein, Roni Shouval, Ivetta Danylesko, Mika Geva, Arnon Nagler, Noga Shem-Tov
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S111-S112
Background Risk stratification is a critical step when considering allogeneic hematopoietic stem cell transplantation (HSCT). While Lactate dehydrogenase (LDH) is a readily available biomarker with a prognostic role in the front-line therapy setting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18c919946a682d7b8dca057a57f8cdc1
https://doi.org/10.1016/j.bbmt.2019.12.620
https://doi.org/10.1016/j.bbmt.2019.12.620